Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini, 5, 80131, Naples, Italy.
Dermatology Clinic, University of Catania, Catania, Italy.
Adv Ther. 2023 Aug;40(8):3381-3394. doi: 10.1007/s12325-023-02555-5. Epub 2023 Jun 12.
The incidence of cutaneous melanoma (CM) is increasing. CM is defined as melanoma in situ when limited within the epidermis and invasive when atypical melanocytes progressively invade the dermis. Treatment of CM is challenging. On one hand, melanoma in situ does not require further treatment except for a limited secondary excision with reduced margins to minimize the risk of local recurrences; on the other, invasive melanoma requires a personalized approach based on tumor staging. Consequently, an association of surgical and medical treatments is often necessary for invasive forms of the disease. In this scenario, new knowledge on melanoma pathogenesis has led to the development of safe and effective treatments, and several drugs are currently under investigation. However, extensive knowledge is required to offer patients a tailored-tail approach. The aim of our article was to review current literature to provide an overview of treatment options for invasive melanoma, highlighting strategical approaches that can be used in patients with these forms of disease.
皮肤黑色素瘤 (CM) 的发病率正在上升。CM 局限于表皮内时定义为原位黑色素瘤,当不典型黑素细胞逐渐浸润真皮时定义为侵袭性黑色素瘤。CM 的治疗具有挑战性。一方面,原位黑色素瘤除了为最大限度地降低局部复发风险而进行有限的边缘缩小的二次切除外,不需要进一步治疗;另一方面,侵袭性黑色素瘤需要根据肿瘤分期制定个性化的治疗方法。因此,对于侵袭性疾病,通常需要手术和药物治疗联合。在这种情况下,对黑色素瘤发病机制的新认识导致了安全有效的治疗方法的发展,目前有几种药物正在研究中。然而,为患者提供量身定制的治疗方法需要广泛的知识。我们的文章旨在回顾当前的文献,为侵袭性黑色素瘤的治疗选择提供概述,突出可用于这些疾病患者的策略性方法。
Adv Ther. 2023-8
Acta Dermatovenerol Croat. 2018-4
J Plast Surg Hand Surg. 2015
JAMA Facial Plast Surg. 2017-5-1
Scand J Plast Reconstr Surg Hand Surg. 1998-3
J Dermatol Surg Oncol. 1982-9
Cancer. 1996-3-1
Diagnostics (Basel). 2025-5-28
Medicina (Kaunas). 2024-5-28
Int J Mol Sci. 2024-4-29
Clin Cosmet Investig Dermatol. 2024-3-21
Int J Mol Sci. 2024-3-4
Dermatol Clin. 2023-1
J Eur Acad Dermatol Venereol. 2023-1
Int J Mol Sci. 2022-6-7
J Cosmet Dermatol. 2022-6
Cancer Immunol Res. 2022-5-3